BiotechTube
Home/LyGenesis/Michael Hufford, PhD
MH

Michael Hufford, PhD

Chief Executive Officer

LyGenesis

Therapeutic Areas

End-Stage Liver DiseaseEnd-Stage Renal DiseaseType 1 DiabetesAging/Immunosenescence

LyGenesis Pipeline

DrugIndicationPhase
Liver Cell TherapyEnd Stage Liver Disease (ESLD)Phase 2A
Thymus Cell TherapyAging/ImmunosenescenceProof of Concept
Kidney Cell TherapyEnd Stage Renal Disease (ESRD)Proof of Concept
Pancreas Cell TherapyType 1 DiabetesProof of Concept

Leadership Team at LyGenesis

PF
Paulo Fontes, MD, FACS
Acting Medical Officer
EL
Eric Lagasse, PharmD, PhD
Chief Scientific Officer
JM
Jim Mellon
Chairman of the Board of Directors
View full LyGenesis profile